Total Payments
$8,415
2024 Payments
$1,384
Companies
38
Transactions
331
Medicare Patients
16,183
Medicare Billing
$1.7M
Payment Breakdown by Category
Food & Beverage$7,220 (85.8%)
Travel$1,105 (13.1%)
Other$73.50 (0.9%)
Education$16.29 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,220 | 323 | 85.8% |
| Travel and Lodging | $1,105 | 3 | 13.1% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $73.50 | 1 | 0.9% |
| Education | $16.29 | 4 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $2,173 | 43 | $0 (2024) |
| Chiesi USA, Inc. | $780.62 | 16 | $0 (2024) |
| Medtronic Vascular, Inc. | $587.37 | 14 | $0 (2019) |
| Impulse Dynamics (USA) Inc. | $562.67 | 19 | $0 (2024) |
| Medtronic, Inc. | $447.89 | 15 | $0 (2024) |
| Edwards Lifesciences Corporation | $421.02 | 7 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $368.23 | 29 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $355.48 | 24 | $0 (2023) |
| Amgen Inc. | $308.57 | 23 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $247.15 | 17 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,384 | 73 | Boston Scientific Corporation ($465.30) |
| 2023 | $1,230 | 52 | Impulse Dynamics (USA) Inc. ($302.90) |
| 2022 | $603.55 | 31 | Medtronic, Inc. ($142.31) |
| 2021 | $497.80 | 27 | BOSTON SCIENTIFIC CORPORATION ($151.94) |
| 2020 | $361.49 | 19 | Esperion Therapeutics, Inc. ($156.98) |
| 2019 | $1,854 | 48 | Boston Scientific Corporation ($1,260) |
| 2018 | $1,369 | 50 | Medtronic Vascular, Inc. ($361.69) |
| 2017 | $1,116 | 31 | Chiesi USA, Inc. ($439.72) |
All Payment Transactions
331 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $4.06 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/18/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/12/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $21.05 | General |
| Category: Cardiovascular | ||||||
| 11/25/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $40.42 | General |
| Category: General - Therapies_CRM | ||||||
| 11/25/2024 | Impulse Dynamics (USA) Inc. | Optimizer (Device), Optimizer | Food and Beverage | Cash or cash equivalent | $22.46 | General |
| Category: Cardiovascular Device | ||||||
| 11/22/2024 | Medtronic, Inc. | COREVALVE EVOLUT R (Device) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: Transcatheter Valve Systems | ||||||
| 11/19/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $13.36 | General |
| Category: Cardiovascular | ||||||
| 11/18/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $18.48 | General |
| Category: Coronary | ||||||
| 11/12/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $116.14 | General |
| Category: General - Therapies_CRM | ||||||
| 11/08/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/07/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/30/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $10.63 | General |
| Category: General - Therapies_CRM | ||||||
| 10/29/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: Obesity | ||||||
| 10/25/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $3.80 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/23/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: Renal Denervation System | ||||||
| 10/04/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/03/2024 | Abbott Laboratories | ESPRIT (Device) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: Vascular | ||||||
| 09/27/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/26/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: Obesity | ||||||
| 09/25/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: General - Therapies_CRM | ||||||
| 09/18/2024 | Boston Scientific Corporation | AVVIGO Guidance System (Device) | Food and Beverage | In-kind items and services | $11.41 | General |
| Category: AVVIGO_IC | ||||||
| 09/17/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $28.79 | General |
| Category: General - Therapies_CRM | ||||||
| 09/13/2024 | Chiesi USA, Inc. | KENGREAL (Drug) | Food and Beverage | Cash or cash equivalent | $23.21 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/06/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 47 | 4,512 | 7,872 | $2.0M | $465,059 |
| 2022 | 47 | 4,408 | 7,347 | $1.8M | $475,239 |
| 2021 | 46 | 3,749 | 5,399 | $1.4M | $415,608 |
| 2020 | 43 | 3,514 | 5,359 | $1.2M | $366,630 |
Total Patients
16,183
Total Services
25,977
Medicare Billing
$1.7M
Procedure Codes
208
All Medicare Procedures & Services
208 procedure records from CMS Medicare Utilization — Page 1 of 9
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 33285 | Insertion of heart rhythm monitor under skin | Office | 2023 | 24 | 24 | $287,256 | $75,438 | 26.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 431 | 750 | $232,278 | $62,758 | 27.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 431 | 664 | $203,922 | $45,282 | 22.2% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 133 | 795 | $277,345 | $42,986 | 15.5% |
| 33208 | Insertion of pacemaker and upper and lower heart chamber electrode | Facility | 2023 | 90 | 90 | $112,710 | $32,108 | 28.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 203 | 208 | $106,788 | $27,759 | 26.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 305 | 325 | $59,665 | $16,548 | 27.7% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 47 | 47 | $54,449 | $14,180 | 26.0% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 271 | 718 | $55,491 | $13,974 | 25.2% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 26 | 31 | $80,538 | $11,795 | 14.6% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 68 | 68 | $49,912 | $11,783 | 23.6% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 296 | 756 | $46,086 | $10,725 | 23.3% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 86 | 549 | $36,868 | $9,142 | 24.8% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 48 | 95 | $9,193 | $6,442 | 70.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 67 | 105 | $18,986 | $6,019 | 31.7% |
| 33361 | Replacement of aortic valve through the skin and femoral artery | Facility | 2023 | 11 | 11 | $32,618 | $5,646 | 17.3% |
| 33228 | Removal and replacement of dual lead permanent pacemaker | Facility | 2023 | 21 | 21 | $18,168 | $5,171 | 28.5% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 87 | 88 | $17,700 | $4,984 | 28.2% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 34 | 130 | $65,990 | $4,770 | 7.2% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 70 | 184 | $24,104 | $4,369 | 18.1% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 49 | 252 | $16,998 | $4,234 | 24.9% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 50 | 55 | $15,380 | $4,194 | 27.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 44 | 44 | $17,511 | $4,043 | 23.1% |
| 33225 | Insertion of left lower heart electrode for pacemaker or defibrillator | Facility | 2023 | 12 | 12 | $13,460 | $3,825 | 28.4% |
| 83880 | Natriuretic peptide (heart and blood vessel protein) level | Office | 2023 | 76 | 96 | $10,309 | $3,658 | 35.5% |
About Dr. Denes Korpas, MD
Dr. Denes Korpas, MD is a Cardiovascular Disease healthcare provider based in Lincoln, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1902992399.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Denes Korpas, MD has received a total of $8,415 in payments from pharmaceutical and medical device companies, with $1,384 received in 2024. These payments were reported across 331 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($7,220).
As a Medicare-enrolled provider, Korpas has provided services to 16,183 Medicare beneficiaries, totaling 25,977 services with total Medicare billing of $1.7M. Data is available for 4 years (2020–2023), covering 208 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology, Internal Medicine
- Location Lincoln, NE
- Active Since 10/05/2006
- Last Updated 02/01/2012
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1902992399
Products in Payments
- GENERAL THERAPIES (Device) $1,217
- KENGREAL (Drug) $498.68
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $376.40
- COREVALVE EVOLUT R (Device) $333.12
- OPTIMIZER (Device) $302.90
- Optimizer (Device) $259.77
- CoreValve Evolut (Device) $250.24
- MULTAQ (Drug) $224.91
- XARELTO (Drug) $201.56
- ENTRESTO (Drug) $194.98
- CAMZYOS (Drug) $188.38
- LEQVIO (Drug) $173.25
- Corlanor (Drug) $166.40
- ELIQUIS (Drug) $162.62
- CLEVIPREX (Drug) $146.39
- CARDENE (Drug) $135.55
- PRALUENT (Drug) $130.57
- Repatha (Biological) $129.81
- Impella (Device) $127.56
- Evera (Device) $125.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Lincoln
Steven Krueger, M.d, M.D
Cardiovascular Disease — Payments: $1.1M
Cardiovascular Disease $1.1M
Keith Miller, M.d, M.D
Cardiovascular Disease — Payments: $76,992
Cardiovascular Disease $76,992
Dr. Gina Mentzer, M.d, M.D
Cardiovascular Disease — Payments: $36,488
Cardiovascular Disease $36,488
Wynn Hunter, M.d., M.h.sc, M.D., M.H.SC
Cardiovascular Disease — Payments: $30,317
Cardiovascular Disease $30,317
Dr. Walid Kutayli, M.d, M.D
Cardiovascular Disease — Payments: $14,372
Cardiovascular Disease $14,372
Dr. John Rodriguez, M.d, M.D
Cardiovascular Disease — Payments: $8,764
Cardiovascular Disease $8,764